Hybrid SA RGP Center/S-H Skirt Daily Wear 90 Day Multicenter Study

Status Completed

Clinical Trial Summary

The purpose of the study is to demonstrate that the SynergEyes SA Hybrid Contact Lens clinical performance is substantially equivalent to that of the SynergEyes A Hybrid Lens when studied:

- within the corresponding range of lens powers

- in a population randomized within multiple investigational sites

- with a study ration of 2/1 test vs control lenses

- for a duration of 90 days.

Clinical Trial Description

The objective of the study is to compare the SynergEyes SA Hybrid Contact Lens (Test) to the SynergEyes A Hybrid Contact lens (Control) when used in a daily wear regimen on non-diseased eyes for the correction of myopia (-0.25 to -6.00Diopters) with up to -2.50 Diopters of astigmatism. The population will be randomized into a 2/1 ratio of the Test/Control for 90 days. The study objective is to complete at least 40 subjects in the Test material and 20 subjects in the Control material.

The purpose of the study is to demonstrate that the SynergEyes SA Hybrid Contact Lens clinical performance is substantially equivalent to that of the SynergEyes A Hybrid Lens when studied within the corresponding range of powers in a population randomized within investigational sites to produce a 2/1 ratio of Test vs. Control lenses. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00804505
Study type	Interventional
Source	SynergEyes, Inc.
Contact
Status	Completed
Phase	N/A
Start date	June 2008
Completion date	December 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04531540` - Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test)	Phase 3
Completed	`NCT00988065` - Sugammadex Hypersensitivity Study (Study P06042)	Phase 1
Completed	`NCT03563066` - Effect of Benralizumab in Atopic Dermatitis	Phase 2
Completed	`NCT02588326` - Sensitivity of Pharmacokinetics to Differences in Particle Size Distribution of Suspension-based Nasal Sprays	Phase 1
Completed	`NCT02916888` - A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists	N/A
Completed	`NCT02360072` - Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma
Completed	`NCT02352168` - Airway Inflammation in Children With Allergic Rhinitis and Intervention	N/A
Completed	`NCT01904604` - Peanut Epicutaneous Phase II Immunotherapy Clinical Trial	Phase 2
Completed	`NCT01494649` - Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity	N/A
Enrolling by invitation	`NCT05039229` - Measures for Bioaerosol Reduction in the Salmon Industry	N/A
Enrolling by invitation	`NCT05675241` - Characterizing the Inflammation Around Dental Implants
Completed	`NCT04006106` - Defining ENDOtypes in Perioperative Hypersensitivity by Extensive Cellular and Molecular PHENotyping (ENDOPHEN)
Completed	`NCT04605471` - A Study to Learn More About the Safety of Ultravist in Children and in the Elderly
Completed	`NCT03720470` - Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy	Phase 3
Terminated	`NCT05247567` - Quaternary Ammonium and Immunization in Hairdressers	N/A
Completed	`NCT05119751` - Vestibular Versus Sublingual Route of AIT Tablets	Phase 4
Recruiting	`NCT06065137` - Standardised Drug Provocation Testing in Perioperative Hypersensitivity	N/A
Active, not recruiting	`NCT05960266` - Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study	Early Phase 1
Not yet recruiting	`NCT04485299` - Clinical Assessment of Bifluorid 10 vs Varnish Fluoride on The Exposed Hypersensitive Cervical Dentin in Adult Patient	Phase 2/Phase 3
Completed	`NCT02686827` - DBPC-Dose-finding-trial of Vitamin D3 for SCIT in Birch Pollen Allergic Patients.	Phase 2